Invention Grant
- Patent Title: Amorphous telithromycin compound
- Patent Title (中): 无定型泰利霉素化合物
-
Application No.: US12159939Application Date: 2007-01-04
-
Publication No.: US08222380B2Publication Date: 2012-07-17
- Inventor: Johannes Ludescher , Ulrich Griesser , Christoph Langes
- Applicant: Johannes Ludescher , Ulrich Griesser , Christoph Langes
- Applicant Address: CH Basel
- Assignee: Sandoz AG
- Current Assignee: Sandoz AG
- Current Assignee Address: CH Basel
- Agency: Luedeka Neely Group, P.C.
- Priority: GB0600238.0 20060106
- International Application: PCT/EP2007/000036 WO 20070104
- International Announcement: WO2007/077219 WO 20070712
- Main IPC: C07H17/08
- IPC: C07H17/08
Abstract:
The present invention relates to stable amorphous 3-De[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribohexopyranosyl)oxy]-11,12-dideoxy-6-O-methyl-3-oxo-12,11-[oxycarbonyl[[4-[4-(3-pyridinyl)-1H-imidazol-1-yl]butyl]imino]]erythromycin (telithromycin), methods for the preparation thereof, the use of stable amorphous telithromycin in the treatment of bacterial infections and to pharmaceutical compositions comprising stable amorphous telithromycin.
Public/Granted literature
- US20080280841A1 Amorphous Telithromycin Compound Public/Granted day:2008-11-13
Information query
